Clinical Trials Directory

Trials / Completed

CompletedNCT02417116

Tear Osmolarity Clinical Utility in Dry Eye Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Aston University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Millions of people suffer from dry eye disease, causing symptoms such as redness, burning, feeling of sand or grit in the eye and light sensitivity. Dry eye disease occurs when your eyes do not produce enough tears or produce poor quality tears. This can happen for a number of reasons, including aging, hormonal changes in women and side effects of diseases or medications. It is now possible to objectively measure the degree of dry eye disease by collecting a tiny sample of tears from the corner of the eye and then measuring the amount of salt in the tears (termed osmolarity). We aim to establish the overall levels of raised and normal tear osmolarity in people presenting to the eye clinic with complaints of dry eye, and relate this to other factors such as symptoms, topical and nutritional medication and dry eye treatment.

Detailed description

This study will investigate the efficacy of two treatment non-pharmaceutical therapies (tear drop alone, tear drop combined with omega 3 nutritional supplement and warm compresses) for dry eye reporting patients against a control (saline) over a 3 month period. A relatively new clinical measure (osmolarity) will be performed alongside traditional tear film volume, tear film stability, gland integrity and ocular surface damage measures to determine how this influences symptomatic complaints.

Conditions

Interventions

TypeNameDescription
OTHERTear supplementApplication as required to improve comfort
OTHERTear supplement 2Application as required to improve comfort
DIETARY_SUPPLEMENTOmega 3 nutrition supplementTaken each day
DEVICEEye bagApplied following microwave heating to closed eyelids for 5 minutes each day
OTHERSalineApplication as required to improve comfort

Timeline

Start date
2015-06-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2015-04-15
Last updated
2019-01-10

Locations

6 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02417116. Inclusion in this directory is not an endorsement.